EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL for Maternal exposure timing unspecified: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL was used for Maternal exposure timing unspecified.
Most Reported Side Effects for EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Bone density decreased | 3,497 | 48.4% | 38 | 156 |
| Renal injury | 2,955 | 40.9% | 43 | 133 |
| Skeletal injury | 2,766 | 38.3% | 40 | 127 |
| Tooth injury | 1,969 | 27.3% | 22 | 82 |
| Tooth loss | 1,968 | 27.2% | 21 | 91 |
| Chronic kidney disease | 1,960 | 27.1% | 47 | 194 |
| Renal failure | 1,600 | 22.2% | 47 | 207 |
| Bone loss | 1,530 | 21.2% | 20 | 74 |
| Osteonecrosis | 1,492 | 20.7% | 22 | 78 |
| Multiple fractures | 1,489 | 20.6% | 23 | 80 |
| Osteoporosis | 1,415 | 19.6% | 14 | 78 |
| Pain | 1,371 | 19.0% | 14 | 126 |
| Emotional distress | 1,356 | 18.8% | 14 | 125 |
| Anxiety | 1,251 | 17.3% | 11 | 120 |
| Anhedonia | 1,207 | 16.7% | 10 | 115 |
Other Indications for EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL
Hiv infection (5,840)
Product used for unknown indication (859)
Acquired immunodeficiency syndrome (427)
Prophylaxis against hiv infection (27)
Antiretroviral therapy (21)
Hepatitis b (21)
Hiv test positive (11)
Other Drugs Used for Maternal exposure timing unspecified
VALPROATE (1,477)
ADALIMUMAB (1,280)
NATALIZUMAB (492)
RITONAVIR (486)
EMTRICITABINE\TENOFOVIR DISOPROXIL (333)
LOPINAVIR\RITONAVIR (278)
DIVALPROEX (254)
INTERFERON BETA-1A (245)
DIMETHYL (212)
ATAZANAVIR (169)